These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 23690666)

  • 1. IL-10 treatment is associated with prohibitin expression in the Crohn's disease intestinal fibrosis mouse model.
    Yuan C; Chen WX; Zhu JS; Chen NW; Lu YM; Ou YX; Chen HQ
    Mediators Inflamm; 2013; 2013():617145. PubMed ID: 23690666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased activation of latent TGF-β1 by αVβ3 in human Crohn's disease and fibrosis in TNBS colitis can be prevented by cilengitide.
    Li C; Flynn RS; Grider JR; Murthy KS; Kellum JM; Akbari H; Kuemmerle JF
    Inflamm Bowel Dis; 2013 Dec; 19(13):2829-39. PubMed ID: 24051933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHE3 modulates the severity of colitis in IL-10-deficient mice.
    Larmonier CB; Laubitz D; Thurston RD; Bucknam AL; Hill FM; Midura-Kiela M; Ramalingam R; Kiela PR; Ghishan FK
    Am J Physiol Gastrointest Liver Physiol; 2011 Jun; 300(6):G998-G1009. PubMed ID: 21415416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Interleukin-17 in Pathogenesis of Intestinal Fibrosis in Mice.
    Li J; Liu L; Zhao Q; Chen M
    Dig Dis Sci; 2020 Jul; 65(7):1971-1979. PubMed ID: 31808003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Noncanonical STAT3 activation regulates excess TGF-β1 and collagen I expression in muscle of stricturing Crohn's disease.
    Li C; Iness A; Yoon J; Grider JR; Murthy KS; Kellum JM; Kuemmerle JF
    J Immunol; 2015 Apr; 194(7):3422-31. PubMed ID: 25740948
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting Interleukin 36 Receptor Signaling Reduces Fibrosis in Mice With Chronic Intestinal Inflammation.
    Scheibe K; Kersten C; Schmied A; Vieth M; Primbs T; Carlé B; Knieling F; Claussen J; Klimowicz AC; Zheng J; Baum P; Meyer S; Schürmann S; Friedrich O; Waldner MJ; Rath T; Wirtz S; Kollias G; Ekici AB; Atreya R; Raymond EL; Mbow ML; Neurath MF; Neufert C
    Gastroenterology; 2019 Mar; 156(4):1082-1097.e11. PubMed ID: 30452921
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cadherin-11 Is a Regulator of Intestinal Fibrosis.
    Franzè E; Monteleone I; Laudisi F; Rizzo A; Dinallo V; Di Fusco D; Colantoni A; Ortenzi A; Giuffrida P; Di Carlo S; Sica GS; Di Sabatino A; Monteleone G
    J Crohns Colitis; 2020 Mar; 14(3):406-417. PubMed ID: 31504344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laquinimod ameliorates spontaneous colitis in interleukin-10-gene-deficient mice with improved barrier function.
    Sun J; Shen X; Dong J; Zhao J; Zuo L; Wang H; Li Y; Zhu W; Gong J; Li J
    Int Immunopharmacol; 2015 Dec; 29(2):423-432. PubMed ID: 26603637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severity of local inflammation does not impact development of fibrosis in mouse models of intestinal fibrosis.
    Hünerwadel A; Fagagnini S; Rogler G; Lutz C; Jaeger SU; Mamie C; Weder B; Ruiz PA; Hausmann M
    Sci Rep; 2018 Oct; 8(1):15182. PubMed ID: 30315190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of ATP-activated P2X7 receptors in the intestinal mucosa is implicated in the pathogenesis of Crohn's disease.
    Neves AR; Castelo-Branco MT; Figliuolo VR; Bernardazzi C; Buongusto F; Yoshimoto A; Nanini HF; Coutinho CM; Carneiro AJ; Coutinho-Silva R; de Souza HS
    Inflamm Bowel Dis; 2014 Mar; 20(3):444-57. PubMed ID: 24412990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-320a Strengthens Intestinal Barrier Function and Follows the Course of Experimental Colitis.
    Cordes F; Brückner M; Lenz P; Veltman K; Glauben R; Siegmund B; Hengst K; Schmidt MA; Cichon C; Bettenworth D
    Inflamm Bowel Dis; 2016 Oct; 22(10):2341-55. PubMed ID: 27607334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IL-10/microRNA-155/SHIP-1 signaling pathway is crucial for commensal bacteria induced spontaneous colitis.
    Li Y; Tian Y; Zhu W; Gong J; Guo Z; Guo F; Gu L; Li J
    Biochem Pharmacol; 2016 Sep; 116():100-6. PubMed ID: 27395764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
    Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy.
    Zhao J; Sun Y; Shi P; Dong JN; Zuo LG; Wang HG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Int Immunopharmacol; 2015 May; 26(1):221-8. PubMed ID: 25858875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin 16 is up-regulated in Crohn's disease and participates in TNBS colitis in mice.
    Keates AC; Castagliuolo I; Cruickshank WW; Qiu B; Arseneau KO; Brazer W; Kelly CP
    Gastroenterology; 2000 Oct; 119(4):972-82. PubMed ID: 11040184
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DHA protects against experimental colitis in IL-10-deficient mice associated with the modulation of intestinal epithelial barrier function.
    Zhao J; Shi P; Sun Y; Sun J; Dong JN; Wang HG; Zuo LG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Br J Nutr; 2015 Jul; 114(2):181-8. PubMed ID: 26104043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipokine apelin ameliorates chronic colitis in Il-10
    Ge Y; Li Y; Chen Q; Zhu W; Zuo L; Guo Z; Gong J; Cao L; Gu L; Li J
    Biochem Pharmacol; 2018 Feb; 148():202-212. PubMed ID: 29309764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNA 301A Promotes Intestinal Inflammation and Colitis-Associated Cancer Development by Inhibiting BTG1.
    He C; Yu T; Shi Y; Ma C; Yang W; Fang L; Sun M; Wu W; Xiao F; Guo F; Chen M; Yang H; Qian J; Cong Y; Liu Z
    Gastroenterology; 2017 May; 152(6):1434-1448.e15. PubMed ID: 28193514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-resolution gene expression profiling using RNA sequencing in patients with inflammatory bowel disease and in mouse models of colitis.
    Holgersen K; Kutlu B; Fox B; Serikawa K; Lord J; Hansen AK; Holm TL
    J Crohns Colitis; 2015 Jun; 9(6):492-506. PubMed ID: 25795566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.